PolymarketBeschikbaarheid controlerenGeen KYC2% kostenGeverifieerde afwikkelingsgegevensRedelijk gekalibreerdHuidige impliciete kansDecember 62%-0.5pt
Marktkwaliteit
42 / 100
Lage kwaliteit24u volume
€ 87,9
Liquiditeit
€ 691,1
Lage liquiditeitBied / Laat
21.0% / 25.0%
Spread
4.0 pt
Gematigde spread7d wijziging
-4.0 pts
Marktdata
Bijgewerkt 23 minuten geleden
23 jun 26, 2:1331 dec 26, 23:59
Trends
Alleen virtueel geld, geen echt geldGeen financieel advies
Gekozen uitkomst
December62%
Volumetrend
$1003 jul18d aan data28 jul
Gerelateerde Markten
When "Will Masking Return"? (widespread mask mandates in the USA)
€ 995,9September 2023: 1%MANIFOLD MARKETS
MANIFOLD MARKETSWill the NIH indirect cost cap stick?
€ 878,8Ja: 11.4%MANIFOLD MARKETS
MANIFOLD MARKETSWill George W Bush outlive Obama?
€ 453,4Ja: 12.3%MANIFOLD MARKETS
MANIFOLD MARKETS
California Clinic Funding Proposition
€ 43,9Ja: 34%POLYMARKET
POLYMARKET
Who will Trump announce as next FDA commissioner?
€ 39,4No announcement by December 31: 41%POLYMARKET
POLYMARKET
What will the average number of measles cases be during Trump's term?
€ 19,6At least 4500: 43%
KALSHI
KALSHIActief in deze onderwerpen
Gerelateerd Nieuws
Polymarket: Vance leads 2028 at 19.85% as pricing trend softensBlockchain.News
White House pushes Senate Democrats to take 'historic' crypto Clarity Act ethics dealCoindesk
Senate nears bipartisan CLARITY Act deal after ethics breakthroughCrypto News
White House agrees to ethics provisions in market structure billCointelegraph
Polymarket odds show Vance at 19.85% as Epstein files critique hits tapeBlockchain.News
Dick Durbin accuses Todd Blanche of shielding Trump’s crypto empireCrypto NewsRegels
This market will resolve to “Yes” if the Food and Drug Administration (FDA) announces that it has reclassified or will reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by the listed date, 11:59 PM ET.
- Otherwise, this market will resolve to “No”.
- A qualifying announcement must be official and public.
- Any rumored or private statements of intention will not qualify.
- Any announcement that the drug has been reclassified to Category 1 will qualify.
- Any announcement within this market’s timeframe of future intention to reclassify to Category 1 will qualify regardless of whether the reclassification has happened by the listed date.